Skip to Main Content

Paper Details

Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system.
Breast Cancer Res Treat
0
2023
ATM, BRCA1, BRCA2, CHEK2, NF1, PALB2, PVs, TP53, breast cancer, breast cancer associated genes, cancer
Author NameAffiliation
Karen J WernliKaiser Permanente Washington Health Research Institute
Karen J WernliKaiser Permanente Washington Health Research Institute
Kathleen F MittendorfKaiser Permanente Center for Health Research
Kathleen F MittendorfVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Heather Spencer FeigelsonInstitute for Health Research, Kaiser Permanente
Gail P JarvikUniversity of Washington
Gail P JarvikUniversity of Washington
Tia L KauffmanKaiser Permanente Center for Health Research
David L VeenstraDepartment of Pharmacy, School of Pharmacy, University of Washington
Benjamin S WilfondUniversity of Washington
Katrina A B GoddardKaiser Permanente Center for Health Research
Katrina A B GoddardNational Cancer Institute
  • 1 - 12

Datasets

Release 1.2